The estimated Net Worth of Track Capital, Lp Deep Trac... is at least $23 million dollars as of 10 May 2024. Track Trac owns over 56,000 units of Nektar Therapeutics stock worth over $22,930,000 and over the last few years Track sold NKTR stock worth over $99,680.
Track has made over 1 trades of the Nektar Therapeutics stock since 2024, according to the Form 4 filled with the SEC. Most recently Track sold 56,000 units of NKTR stock worth $99,680 on 10 May 2024.
The largest trade Track's ever made was selling 56,000 units of Nektar Therapeutics stock on 10 May 2024 worth over $99,680. On average, Track trades about 56,000 units every 0 days since 2024. As of 10 May 2024 Track still owns at least 18,344,000 units of Nektar Therapeutics stock.
You can see the complete history of Track Trac stock trades at the bottom of the page.
Over the last 21 years, insiders at Nektar Therapeutics have traded over $57,608,493 worth of Nektar Therapeutics stock and bought 90,000 units worth $1,628,550 . The most active insiders traders include Howard W Robin, Gil M Labrucherie et John Nicholson. On average, Nektar Therapeutics executives and independent directors trade stock every 11 days with the average trade being worth of $36,648. The most recent stock trade was executed by Jonathan Zalevsky on 19 August 2024, trading 6,866 units of NKTR stock currently worth $8,788.
nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.
Nektar Therapeutics executives and other stock owners filed with the SEC include: